Relay Therapeutics, Inc.Relay Therapeutics, Inc.Relay Therapeutics, Inc.

Relay Therapeutics, Inc.

No trades
See on Supercharts

Price target

23.050.00 0.00%
The 11 analysts offering 1 year price forecasts for RLAY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 12 analysts giving stock ratings to RLAY in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

RLAY EPS for the last quarter is −0.67 USD despite the estimation of −0.72 USD. In the next quarter EPS is expected to reach −0.74 USD. Track more of Relay Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Relay Therapeutics, Inc. revenue is expected to reach ‪120.00 K‬ USD. Check out Relay Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RLAY price target is 23.05 USD with a max estimate of 33.00 USD and a min estimate of 10.60 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with RLAY news and stock market news.
We've gathered opinions of 12 analysts rating RLAY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.